Invest Policy
No Result
View All Result
Thursday, February 25, 2021
  • Login
  • Latest News
  • Banking
  • Economy
  • Market
  • Investment Plans
    • Mutual Funds
    • Money
    • Property
    • Scheme
  • Finance
  • Insurance
    • General Insurance
    • Life Insurance
    • LIC
  • World
Subscribe
Invest Policy
  • Latest News
  • Banking
  • Economy
  • Market
  • Investment Plans
    • Mutual Funds
    • Money
    • Property
    • Scheme
  • Finance
  • Insurance
    • General Insurance
    • Life Insurance
    • LIC
  • World
No Result
View All Result
Invest Policy
No Result
View All Result
Home Market

TORRENT PHARMA announces Rs 20 per share interim dividend, know the stock opinion from brokerage

by InvestPolicy
February 10, 2021
in Market
0
TORRENT PHARMA announces Rs 20 per share interim dividend, know the stock opinion from brokerage
152
SHARES
1.9k
VIEWS
Share on FacebookShare on Twitter

 

TORRENT PHARMA reported a year-on-year growth of 18.3 per cent in the third quarter. The company reported a profit of Rs 297 crore in the third quarter of FY 2021 as against a profit of Rs 251 crore in the same quarter last year.

The company’s revenue has also increased in the third quarter. On an annual basis, the company’s revenue grew 1.5 per cent to Rs 1,995 crore in the third quarter from Rs 1,966 crore in the same quarter last year.

Growth is under pressure in the US and Brazil markets and growth in domestic business remains sluggish. The company has announced an interim dividend of Rs 20 per share. Know what is the investment opinion of brokerage

TORRENT PHARMA

Opinion on CREDIT SUISSE TORRENT PHARMA

CREDIT SUISSE gave an underperform rating on TORRENT PHARMA and set the target at Rs 2280. He says the sector has outperformed and margins have been strong. On the other hand, there are signs of weakness in US markets. But Indian business is expected to continue to grow better. He has said that the stock’s position in the medium term is attractive and at the same time has lowered the EPS estimate of the stock by 2 percent for FY 2021-23.

CLSA’s opinion on TORRENT PHARMA

CLSA has a buy rating on TORRENT PHARMA and set the target at Rs 3560.

Opinions on TORRENT PHARMA by GOLDMAN SACHS

GOLDMAN SACHS has Buy rating on TORRENT PHARMA and set the target at Rs 3320.

Opinions on CITI’s TORRENT PHARMA

CITI has given a buy rating on TORRENT PHARMA and has set a target of Rs 3100.

Kanyadan vs Sukanya

LIC Policy Revival

Tags: AxisBrokerageCityCLSAGoldman saxJefferiesJp morganMacquarieMotilal OsavThe resultTorrent Pharma
  • Trending
  • Comments
  • Latest
MP E Uparjan

MP E Uparjan 2021 | Farmer online registration, mpeuparjan.nic.in portal

January 25, 2021
sukanya-samriddhi-yojana-vs-lic-kanyadan-policy

LIC Kanyadan Policy Vs Sukanya Samriddhi Yojana

May 11, 2020
RailTel IPO: Premium falls in gray market, should you still invest?

Nureca’s IPO will open for subscription on February 15, should it subscribe or not? Know the opinion of experts

February 10, 2021
Nureca IPO: दूसरे दिन 13.66 गुना सब्सक्राइब हुआ IPO, रिटेल पोर्शन 74 गुना बुक, QIB पोर्शन नहीं हुआ बुक

Nureca IPO: IPO subscribed 13.66 times on second day, retail portions booked 74 times, QIB portions not booked

February 16, 2021
top-5-best-lic-plans-2019

Top 5 Best LIC Plans India in 2020 – Reviews

4
lic-tech-term-plan

LIC Tech Term Plan – A Protection Plan For Indian Family

3
lic-policy-status

How To Check LIC Policy Status? – Step By Step Process

3
sukanya-samriddhi-yojana-vs-lic-kanyadan-policy

LIC Kanyadan Policy Vs Sukanya Samriddhi Yojana

2
Under this scheme, every farmer has received 14000 rupees so far, 10.75 crore farmers have benefited, what have you got?

Under this scheme, every farmer has received 14000 rupees so far, 10.75 crore farmers have benefited, what have you got?

February 25, 2021
Fierce scene of military revolt, angry soldiers hostage more than 50 top officers, then put to death

Fierce scene of military revolt, angry soldiers hostage more than 50 top officers, then put to death

February 25, 2021
PNB scam case: British court will give verdict in Nirav Modi's extradition case today

PNB scam case: British court will give verdict in Nirav Modi’s extradition case today

February 25, 2021
Meat eating disease spread in many parts of Australia.

Meat eating disease spread in many parts of Australia.

February 25, 2021

Recent News

Under this scheme, every farmer has received 14000 rupees so far, 10.75 crore farmers have benefited, what have you got?

Under this scheme, every farmer has received 14000 rupees so far, 10.75 crore farmers have benefited, what have you got?

February 25, 2021
Fierce scene of military revolt, angry soldiers hostage more than 50 top officers, then put to death

Fierce scene of military revolt, angry soldiers hostage more than 50 top officers, then put to death

February 25, 2021

Categories

  • Banking
  • Economy
  • Featured
  • Finance
  • General Insurance
  • Health Insurance
  • Insurance
  • Investment Plans
  • Latest News
  • LIC
  • Life Insurance
  • Market
  • Money
  • Mutual Funds
  • Property
  • Scheme
  • World

Site Navigation

  • Home
  • Advertisement
  • Contact Us
  • Privacy & Policy
  • Other Links

InvestPolicy.com is one of the leading companies when it comes to loans and card marketplace. Our main motto is to help our customers in making personal finance decisions easy and convenient as per their comfort.

© 2021 Invest Policy. All Right Reserved.

No Result
View All Result
  • Latest News
  • Banking
  • Economy
  • Market
  • Investment Plans
    • Mutual Funds
    • Money
    • Property
    • Scheme
  • Finance
  • Insurance
    • General Insurance
    • Life Insurance
    • LIC
  • World
  • About Us
  • Contact Us

© 2021 Invest Policy. All Right Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In